AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,859,000 | +22.9% | 197,716 | 0.0% | 0.00% | – |
Q2 2020 | $1,513,000 | +23.8% | 197,716 | 0.0% | 0.00% | – |
Q1 2020 | $1,222,000 | -49.2% | 197,716 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $2,406,000 | +5.3% | 197,716 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,284,000 | +15.6% | 197,716 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,975,000 | -47.7% | 197,716 | -32.6% | 0.00% | 0.0% |
Q1 2019 | $3,776,000 | -15.2% | 293,198 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $4,454,000 | -24.0% | 293,198 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $5,864,000 | +2.6% | 293,198 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $5,717,000 | -3.2% | 293,198 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,908,000 | -39.7% | 293,198 | -60.4% | 0.00% | -50.0% |
Q4 2017 | $9,801,000 | -28.2% | 739,666 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $13,647,000 | +0.3% | 739,666 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $13,610,000 | -3.0% | 739,666 | +18.9% | 0.01% | -16.7% |
Q1 2017 | $14,028,000 | -29.6% | 622,066 | +8.7% | 0.01% | -33.3% |
Q4 2016 | $19,914,000 | +125.6% | 572,239 | +51.7% | 0.01% | +125.0% |
Q3 2016 | $8,828,000 | +16.2% | 377,106 | +18.7% | 0.00% | 0.0% |
Q2 2016 | $7,596,000 | +2.2% | 317,567 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $7,431,000 | -22.5% | 317,567 | 0.0% | 0.00% | -20.0% |
Q4 2015 | $9,587,000 | -24.0% | 317,567 | 0.0% | 0.01% | -28.6% |
Q3 2015 | $12,617,000 | +508.9% | 317,567 | +958.6% | 0.01% | +600.0% |
Q2 2015 | $2,072,000 | +89.6% | 30,000 | +50.0% | 0.00% | 0.0% |
Q1 2015 | $1,093,000 | -55.4% | 20,000 | -74.0% | 0.00% | 0.0% |
Q3 2014 | $2,451,000 | -68.4% | 76,824 | -79.5% | 0.00% | -50.0% |
Q2 2014 | $7,764,000 | +114.1% | 374,736 | +100.0% | 0.00% | 0.0% |
Q1 2014 | $3,626,000 | -20.3% | 187,368 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $4,547,000 | +13.0% | 187,368 | 0.0% | 0.00% | +50.0% |
Q3 2013 | $4,024,000 | -1.8% | 187,368 | +1.7% | 0.00% | -33.3% |
Q2 2013 | $4,098,000 | +102.4% | 184,168 | +116.9% | 0.00% | +200.0% |
Q1 2013 | $2,025,000 | +34.4% | 84,908 | 0.0% | 0.00% | 0.0% |
Q3 2012 | $1,507,000 | +14.6% | 84,908 | 0.0% | 0.00% | 0.0% |
Q2 2012 | $1,315,000 | – | 84,908 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |